Recombinant Viral B18R Protein, CF
Recombinant Viral B18R Protein, CF Summary
Accession # P25213
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
|Formulation||Lyophilized from a 0.2 μm filtered solution in PBS.|
|Reconstitution||Reconstitute at 500 μg/mL in PBS.|
|Shipping||The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.|
|Stability & Storage:||Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
The viral type I IFN receptor, B18R, inhibits the anti-viral activity of Recombinant Human IFN-alpha 2. The ED50 for this effect is 0.3-1.8 ng/mL.
(Soluble IFN alpha/beta receptor B18) is a 60-65 kDa protein
encoded by the Vaccinia virus genome and by the genomes of other
orthopoxviruses. Its function represents one of several mechanisms used
by these viruses to evade the host immune response (1, 2). It is known
as B18R in the Western Reserve (WR) strain of Vaccinia but as B19R in
the Copenhagen strain (3). There is a structurally-unrelated, larger
Vaccinia protein that is also known as B18R (or B16R) that contains
multiple ankyrin-like repeats (4). The soluble IFN receptor B18R,
however, contains three immunoglobulin-like domains and shows homology
to human, mouse, and bovine type I IFN receptors (5). The Wyeth
strain of Vaccinia virus encodes a truncated protein that lacks the
C-terminal Ig-like domain, and B18R is functionally absent in the Lister
strain (6, 7). B18R functions as a decoy receptor for type I
IFNs (IFN alpha, beta, omega). It binds to type I IFNs from multiple species and prevents IFN signaling through its receptors
(6-8). B18R binds to the surface of virus infected and uninfected cells
where it retains its capacity to bind and neutralize IFN (6, 8). It
shields those cells from the antiviral effects of type I IFNs,
thereby enabling virus replication and pathogenicity (6-8). B18R also
limits the effectiveness of IFN alpha produced following TLR activation
(9), and it limits adaptive T cell responses (3). The B18R viral protein also acts to protect cells during mRNA transfection to produce induced pluripotent stem cells (iPSCs) from somatic cells (10). The addition of B18R results in increased cell viability of iPSCs in the presence of modified synthetic mRNAs such as OCT4, SOX2, KLF4, MYC, NANOG, and LIN28A. Using mRNAs in combination with B18R allows for integration-free reprogramming of somatic cells to iPSCs without the use of viral vectors or genomic modification.
- Smith, G.L. et al. (2013) J. Gen. Virol. 94:2367.
- Perdiguero, B. and M. Esteban (2009) J. Interferon Cytokine Res. 29:581.
- Gomez, C.E. et al. (2012) J. Virol. 86:5026.
- Goebel, S.J. et al. (1990) Virology 179:247.
- Smith, G.L. and Y.S. Chan (1991) J. Gen. Virol. 72:511.
- Alcami, A. et al. (2000) J. Virol. 74:11230.
- Symons, J.A. et al. (1995) Cell 81:551.
- Colamonici, O.R. et al. (1995) J. Biol. Chem. 270:15974.
- Waibler, Z. et al. (2009) J. Virol. 83:1563.
- Warren, L. et al. (2010) Cell Stem Cell. 7:618.
Citations for Recombinant Viral B18R Protein, CF
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
Citations: Showing 1 - 3
Filter your results:
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses
Authors: Q Chen, M Coto-Llere, A Suslov, RD Teixeira, I Fofana, S Nuciforo, M Hofmann, R Thimme, N Hensel, V Lohmann, CKY Ng, G Rosenberge, S Wieland, MH Heim
Nature Communications, 2021-08-12;12(1):4882.
Sample Types: Whole Cells
MicroRNA Profiles in Monocyte-Derived Macrophages Generated by Interleukin-27 and Human Serum: Identification of a Novel HIV-Inhibiting and Autophagy-Inducing MicroRNA
Authors: T Imamichi, S Goswami, X Hu, S Laverdure, J Yang, J Qiu, Q Chen, BT Sherman, W Chang
International Journal of Molecular Sciences, 2021-01-28;22(3):.
Sample Types: Whole Cells
Modulation of Extracellular ISG15 Signaling by Pathogens and Viral Effector Proteins
Authors: CD Swaim, LA Canadeo, KJ Monte, S Khanna, DJ Lenschow, JM Huibregtse
Cell Rep, 2020-06-16;31(11):107772.
Species: Human, Mouse
Sample Types: Whole Cells
No product specific FAQs exist for this product, however you mayView all Proteins and Enzyme FAQs
Reviews for Recombinant Viral B18R Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Viral B18R Protein, CF and earn rewards!
Have you used Recombinant Viral B18R Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image